Position history for Amova Asset Management Americas, Inc.'s holdings in CRISPR THERAPEUTICS AG
Amova Asset Management Americas, Inc. holds 2M shares of CRSP (CRISPR THERAPEUTICS AG), worth $102.6M as of 2025-Q4. The position was decreased (-9.5% shares). CRSP represents 1.2% of Amova Asset Management Americas, Inc.'s portfolio.
Current Value
$102.6M
Current Shares
2M
Total Value Change
-$67.4M
Total Shares Change
-1.2M
Other major holders of CRSP: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A.
Decreased |
| 2M |
-9.5% |
| $102.6M |
| 1.2% |
| $53.19 |
0 |
| 2025-Q3 | Decreased | 2.2M | -10.4% | $140.2M | 1.4% | $63.77 | 0 |
| 2025-Q2 | Decreased | 2.4M | -5.0% | $117.4M | 1.2% | $47.49 | 0 |
| 2025-Q1 | Decreased | 2.5M | -7.5% | $86.3M | 1.1% | $36.99 | 0 |
| 2024-Q4 | Decreased | 2.7M | -7.5% | $108.1M | 1.2% | $38.65 | 0 |
| 2024-Q3 | Decreased | 3M | -5.8% | $139.4M | 1.6% | $47.32 | 0 |
| 2024-Q2 | Decreased | 3.2M | -3.6% | $170M | 2.0% | $54.01 | 0 |